Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 3 |
2011 | 1 |
2013 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
Cerebrovasc Dis. 2009;27 Suppl 3:28-32. doi: 10.1159/000209263. Epub 2009 May 14.
Cerebrovasc Dis. 2009.
PMID: 19439938
Review.
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators.
Bousser MG, et al.
Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16.
Cerebrovasc Dis. 2009.
PMID: 19372653
Free article.
Clinical Trial.
Item in Clipboard
The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM; PERFORM Study Investigators.
Bousser MG, et al.
Cerebrovasc Dis. 2009;27(6):608-13. doi: 10.1159/000216835. Epub 2009 Apr 30.
Cerebrovasc Dis. 2009.
PMID: 19407444
Free article.
Clinical Trial.
Item in Clipboard
Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population.
Fox K, Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators.
Fox K, et al.
Int J Cardiol. 2013 Oct 9;168(4):3500-5. doi: 10.1016/j.ijcard.2013.04.206. Epub 2013 May 22.
Int J Cardiol. 2013.
PMID: 23706327
Clinical Trial.
Item in Clipboard
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators.
Bousser MG, et al.
Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25.
Lancet. 2011.
PMID: 21616527
Clinical Trial.
Item in Clipboard
Patient- and family-centered performance measures focused on actionable processes of care for persistent and chronic critical illness: protocol for a systematic review.
Rose L, Istanboulian L, Allum L, Burry L, Dale C, Hart N, Kydonaki C, Ramsay P, Pattison N, Connolly B; PERFORM study investigators.
Rose L, et al.
Syst Rev. 2017 Apr 17;6(1):84. doi: 10.1186/s13643-017-0476-9.
Syst Rev. 2017.
PMID: 28416020
Free PMC article.
Item in Clipboard
Cite
Cite